These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12514422)

  • 1. Relationship between antiretroviral drug plasma concentrations and viral load in children.
    Treluyer JM; Burgard M; Cazali N; Quartier P; Veber F; Rey E; Alkaer G; Rouzioux C; Pons G; Blanche S
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):112-5. PubMed ID: 12514422
    [No Abstract]   [Full Text] [Related]  

  • 2. Variations in HIV-RNA viral load and CD4 counts of infants and children receiving antiretroviral drug therapy.
    Sever JL; Rakusan TA; Loechelt B; Schutzbank T; Zamer S; O'Donnell R; Price MV
    J Clin Virol; 1999 Jan; 12(1):71-4. PubMed ID: 10073416
    [No Abstract]   [Full Text] [Related]  

  • 3. HAART does not stop all HIV replication.
    Res Initiat Treat Action; 1999 Dec; 5(5):23-4. PubMed ID: 11366891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pros and cons of therapeutic drug monitoring of antiretroviral agents.
    Burger DM; Aarnoutse RE; Hugen PW
    Curr Opin Infect Dis; 2002 Feb; 15(1):17-22. PubMed ID: 11964901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of treatment failure in Cambodian children with human immunodeficiency virus infection.
    Beldjebel I; Vujcikova J; Sokolova J; Krcmery V
    Pediatr Infect Dis J; 2010 Jun; 29(6):580-1; author reply 581. PubMed ID: 20508485
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV viral load monitoring.
    Richman D; Crowe S; Harvey K
    Adv Exp Med Biol; 1999; 458():199-212. PubMed ID: 10549392
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic and virologic responses to antiretroviral therapy in treatment-naïve, HIV-infected elderly patients.
    Ocheretyaner ER; Yusuff J; Park TE
    Int J STD AIDS; 2019 Nov; 30(13):1304-1310. PubMed ID: 31726933
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
    Giuliano M; Guidotti G; Andreotti M; Pirillo MF; Villani P; Liotta G; Marazzi MC; Mancini MG; Cusato M; Germano P; Loureiro S; Ceffa S; Regazzi M; Vella S; Palombi L
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):286-91. PubMed ID: 17146372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV viral load and preventive HIV load in primary health care].
    Vall Mayans M
    Aten Primaria; 1997 Nov; 20(8):399-400. PubMed ID: 9462932
    [No Abstract]   [Full Text] [Related]  

  • 10. Residual HIV-1 RNA after highly active antiretroviral therapy.
    Onuigbo MA
    JAMA; 2000 Mar; 283(9):1138-9. PubMed ID: 10703769
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy.
    Maggiolo F; Bottura P; Capra R; Pirali A; Zaffaroni P; Suter F
    AIDS; 1999 Aug; 13(12):1594-5. PubMed ID: 10465093
    [No Abstract]   [Full Text] [Related]  

  • 12. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
    Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
    Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma.
    Lorello G; la Porte C; Pilon R; Zhang G; Karnauchow T; MacPherson P
    HIV Med; 2009 Oct; 10(9):548-54. PubMed ID: 19515092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report from the XVIII International HIV Drug Resistance Workshop.
    Kuritzkes DR
    J Watch AIDS Clin Care; 2009 Oct; 21(10):85-6. PubMed ID: 20458804
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care.
    Dickinson BP; Mitty JA; Mylonakis E; Rich JD; Merriman NA; Tashima KT; Carpenter CC; Flanigan TP
    AIDS; 1998 Oct; 12(15):2075-6. PubMed ID: 9814878
    [No Abstract]   [Full Text] [Related]  

  • 16. Duration of viral suppression in patients on stable therapy for HIV-1 infection is predicted by plasma HIV RNA level after 1 month of treatment.
    Maggiolo F; Migliorino M; Pirali A; Pravettoni G; Caprioli S; Suter F
    J Acquir Immune Defic Syndr; 2000 Sep; 25(1):36-43. PubMed ID: 11064502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.
    Langford D; Marquie-Beck J; de Almeida S; Lazzaretto D; Letendre S; Grant I; McCutchan JA; Masliah E; Ellis RJ
    J Neurovirol; 2006 Apr; 12(2):100-7. PubMed ID: 16798671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months.
    Katzenstein TL; Ullum H; Røge BT; Wandall J; Dickmeiss E; Barrington T; Skinhøj P; Gerstoft J
    HIV Med; 2003 Jan; 4(1):53-61. PubMed ID: 12534960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of subtherapeutic plasma concentrations of efavirenz in children.
    Ren Y; Nuttall JJ; Egbers C; Eley BS; Meyers TM; Smith PJ; Maartens G; McIlleron HM
    J Acquir Immune Defic Syndr; 2007 Jun; 45(2):133-6. PubMed ID: 17417100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When to start, when to STI (or, groping for the golden moment).
    Mascolini M
    IAPAC Mon; 2001 Apr; 7(4):114-7, 120-31. PubMed ID: 11700605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.